Zacks Investment Research
23 Sept 2026, 10:30 UTC · 5h ago
Verdict
Headline takes no side. We score HALO +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 85% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
Halozyme is expected to report quarterly earnings of $2.25 per share, a 30.8% increase year-over-year.
Priced inanalysis of upcoming report estimates
So whatA beat on this $2.25 estimate in the next print would likely accelerate the current price momentum.
More positive than 92% of claims this week
Quarterly revenues for Halozyme are expected to reach $470.95 million, representing a 32.9% increase from the year-ago quarter.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Priced inanalysis of upcoming report estimates
So whatRevenue growth exceeding 30% suggests strong adoption of ENHANZE technology across partner pipelines.
More positive than 85% of claims this week
The consensus EPS estimate for the upcoming quarter has been revised 2.6% higher over the last 30 days.
Priced intrend over the last 30 days
So whatPositive revisions typically precede price appreciation, suggesting a potential move toward $120+ if the trend continues.
More positive than 63% of claims this week
Halozyme shares rose 3.3% to $115.13 in the last trading session on higher-than-average volume.
Priced inreport of last trading session
So whatThe move is modest compared to the 30%+ expected growth in earnings and revenue.
More positive than 50% of claims this week
Which stocks this story touches
More positive than 85% of ticker scores this week
Stock price rose on high volume due to optimism over collaboration deals and positive earnings estimate revisions.
More positive than 57% of ticker scores this week
Stock closed the last session 5.6% higher and maintains a Zacks Rank #2 (Buy), despite a poor monthly return.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
52m ago
−0.7%
Price is moving against the score
$114.27 vs $115.13 close before publication (Sep 22) · not market-adjusted
HALO chart →
